- STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patientsThe FDA approved a T-cell therapy from Orca Bio that reduces the risk of a debilitating immune reaction in patients with blood cancers undergoing stem cell transplants.STAT · 25d ago↗ source
- STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenesDemand for alcohol is declining. The industry is fighting harder and more creatively than ever against limits — and winning.STAT · 25d ago↗ source
- STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watchHere is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter.STAT · 25d ago